Brief: Tscan Therapeutics Secures Convertible Debt Facility For Up To $60 Million With K2 Healthventures
12/09/2022 12:04
Sept 12 (Reuters) - TScan Therapeutics Inc TCRX.O :
* TSCAN THERAPEUTICS SECURES CONVERTIBLE DEBT FACILITY FOR
UP TO
$60 MILLION WITH K2 HEALTHVENTURES
* TSCAN THERAPEUTICS INC - INITIAL $30 MILLION TRANCHE
EXTENDS
CASH RUNWAY INTO Q2 OF 2024
Source text for Eikon: ID:nGNX5qP1hk
Further company coverage: TCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tscan Therapeutics
See all newsU.S. RESEARCH ROUNDUP-Broadcom, Deere & Co, Snowflake
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp
U.S. STOCKS ON THE MOVE-AEVEX, Sirius XM, PG&E
U.S. STOCKS ON THE MOVE-TScan Therapeutics, EOS Energy, Brown-Forman Corp
Brief: TScan Therapeutics - Amgen To Terminate Research Collaboration And License Agreement With TScan Therapeutics - SEC Filing